https://events.jspargo.com/Astro22/CUSTOM/corporatemember.png
Naveris Inc. is a molecular diagnostics company developing and commercializing blood and saliva tests to transform the early detection and clinical management of viral-driven cancers. The company’s NavDx® test, which uses proprietary technology to detect tumor-tissue–modified viral (TTMV®)-HPV DNA, is ordered by 250+ medical centers across the US.